The revised Pharmaceutical Law and strategic investments are paving the way for Imexpharm’s high growth in 2025, with a bold revenue target of approximately 3...
On November 19, 2024, Imexpharm Pharmaceutical Joint Stock Company was proudly recognized as the Top #1 Best Place to Work for 2024 in the Pharmaceutical, Medical...
The pharmaceutical sector of Việt Nam was considered to have large potential for growth, driven by the country’s rapid growing middle class, the demand...
VN
EN